Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 129 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Antihypertensive Agents  [Clear All Filters]
2019
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection.. Future Med Chem. 11(11), 1285-1303.
Bikos, A., Loutradis C., Angeloudi E., Karpetas A., Raptis V., Kalaitzidis R., et al. (2019).  The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study.. J Hypertens. 37(2), 432-442.
Georgianos, P. I., Liakopoulos V., & Zebekakis P. E. (2019).  Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions.. J Clin Hypertens (Greenwich). 21(2), 249-251.
Loutradis, C., Bikos A., Raptis V., Afkou Z., Tzanis G., Pyrgidis N., et al. (2019).  Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension.. Hypertens Res. 42(7), 1001-1010.
Sarafidis, P. A., Mallamaci F., Loutradis C., Ekart R., Torino C., Karpetas A., et al. (2019).  Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.. Nephrol Dial Transplant. 34(9), 1542-1548.
2018
Georgianou, E., Georgianos P. I., Petidis K., Athyros V. G., Sarafidis P. A., & Karagiannis A. (2018).  Antihypertensive therapy in acute ischemic stroke: where do we stand?. J Hum Hypertens. 32(12), 799-807.
Georgianos, P. I., Pikilidou M. I., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2018).  Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials.. Hypertens Res. 41(5), 309-319.
Sarafidis, P. A., Ruilope L. M., Loutradis C., Gorostidi M., de la Sierra A., de la Cruz J. J., et al. (2018).  Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.. J Hypertens. 36(5), 1076-1085.
Antza, C., Doundoulakis I., Stabouli S., & Kotsis V. (2018).  Comparison Among Recommendations for the Management of Arterial Hypertension Issued by Last US, Canadian, British and European Guidelines.. High Blood Press Cardiovasc Prev. 25(1), 9-16.
Mitsiou, E., Boutari C., Kotsis V., Georgianou E., Doumas M., Karagiannis A., et al. (2018).  Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension.. Curr Vasc Pharmacol. 16(4), 393-400.
Papadopoulou, E., Angeloudi E., Karras S., & Sarafidis P. (2018).  The optimal blood pressure target in diabetes mellitus: a quest coming to an end?. J Hum Hypertens. 32(10), 641-650.
Founti, P., Coleman A. L., M Wilson R., Yu F., Anastasopoulos E., Harris A., et al. (2018).  Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study.. Acta Ophthalmol. 96(7), e859-e864.
Konstas, A-G., Katsanos A., Athanasopoulos G. P., Voudouragkaki I. C., Panagiotou E. S., Pagkalidou E., et al. (2018).  Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients.. Expert Opin Pharmacother. 19(18), 1981-1988.
2017
Konstas, A-G., Boboridis K. G., Kapis P., Marinopoulos K., Voudouragkaki I. C., Panayiotou D., et al. (2017).  24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe. Adv Ther. 34(1), 221-235.
Kalouda, P., Keskini C., Anastasopoulos E., & Topouzis F. (2017).  Achievements and Limits of Current Medical Therapy of Glaucoma.. Dev Ophthalmol. 59, 1-14.
Liakos, C. I., Papadopoulos D. P., & Kotsis V. T. (2017).  Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice. Am J Cardiovasc Drugs. 17(5), 391-398.
Sarafidis, P. A., Lazaridis A. A., Ruiz-Hurtado G., & Ruilope L. M. (2017).  Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.. Nat Rev Endocrinol. 13(6), 365-374.
Loutradis, C. N., Tsioufis C., & Sarafidis P. A. (2017).  The Clinical Problems of Hypertension Treatment in Hemodialysis Patients.. Curr Vasc Pharmacol. 16(1), 54-60.
Doumas, M., Boutari C., Tsioufis C., Dimitriadis K., Triantafyllou A., & Douma S. (2017).  Clinical Value of Measuring the Renin/Aldosterone Levels: Optimising the Management of Uncontrolled/Resistant Hypertension.. Curr Vasc Pharmacol. 16(1), 10-14.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2017).  Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke.. Clin Exp Hypertens. 39(3), 246-250.
Sarafidis, P. A., Persu A., Agarwal, iv R., Burnier M., de Leeuw P., Ferro C. J., et al. (2017).  Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidne. Nephrol Dial Transplant. 32(4), 620-640.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.